Mesothelioma UCLA
➡️ http://MesotheliomaUSA.net




Since 1997, UCLA's Comprehensive Mesothelioma Program has been using lung-sparing surgery and innovative postoperative therapies that stress quality of life as well as survival. Patients benefit from UCLA's expertise in performing a meticulous procedure (pleurectomy and decortication) that removes all visible tumor from the chest while sparing normal structures, such as the lung, pericardium and diaphragm.

The surgery is followed by precise radiation therapy to target remaining cancer cells and avoid injury to the preserved lung. Patients also benefit from a number of existing and investigational therapies to target the remaining microscopic disease and slow its re-growth.

Recognizing that mesothelioma cannot be entirely eliminated from the body, our physicians treat it as they would any chronic condition. That means we use frequent (often daily) well-tolerated therapies to slow its growth rather than using concentrated treatments whose toxicities may be excessive. UCLA has pioneered the use of therapies such as immunotherapy and cryoablation, which have led to significant advances in the care of patients with this condition. Dr. Robert Cameron founded the program.

Treatment of sarcomatoid mesothelioma.

Patients with sarcomatoid mesothelioma benefit from UCLA's expertise in this rare disease. We have found that chemotherapy agents typically used to treat sarcomas in other areas of the body are more effective in these patients than are the typical mesothelioma chemotherapy agents. This chemotherapy, followed by surgery and radiation, has provided significant advantages for patients in this small group. All patients are treated by a multidisciplinary team. A dedicated nurse practitioner helps to coordinate care and is available to answer questions from patients and referring physicians.

Research.

UCLA Comprehensive Mesothelioma Program physicians collaborate with basic scientists at UCLA, West Los Angeles VA Medical Center, and the Pacific Meso Center at the Pacific Heart, Lung, & Blood Institute.

Our Services.

Patients with all stages of mesothelioma are provided with expert surgical, radiation and medical oncology services.

Surgical techniques include lung-sparing tumor surgery (pleurectomy and decortication or P/D), lasers, bronchial (airway) and esophageal stents and video-and computer-assisted robotic surgery.
Radiation therapy techniques include stereotactic body radiation therapy (SBRT), intensity-modulated radiation therapy (IMRT) and radiosurgery using the Novalis Tx image-guided system.
Chemotherapy, immunotherapy and targeted biologic agents are chosen based on extensive experience treating mesothelioma.

What is mesothelioma?

Mesothelioma is a tumor of the tissue that lines your lungs, called the pleura. Mesothelioma usually starts in the pleura of the lungs, but it can also start in the abdomen or other organs. Often, mesothelioma presents with fluid surrounding the lungs.

Risk Factors.

Asbestos exposure.

Symptoms.

Trouble breathing.
Cough.
Pain under the rib cage.
Pain, swelling, or lumps in the abdomen.
Constipation.
Weight loss for no known reason.

Diagnosis and Screenings.

At times, it is hard to tell the difference between malignant mesothelioma and metastases to the pleura. Imaging tests and biopsies are used to make the diagnosis.

Treatments.

Traditional treatment may include surgery, radiation,and chemotherapy at UCLA, we have established a working group to manage recurrent mesothelioma with minimal invasive image guided cryoablation. Using this technique, up to 90% of local recurrent tumors can be controlled with limited complications.

Mesothelioma UCLA - Treatment of Sarcomatoid Mesothelioma
https://www.youtube.com/watch?v=oS4JfqYOVD8
https://www.youtube.com/channe....l/UCPhQmbwbQCspqO0e1

#mesotheliomaucla #uclamesotheliomaprogram #malignantmesothelioma #treatmentofsarcomatoidmesothelioma

🔗 http://surgery.ucla.edu/compre....hensive-mesothelioma

Chrysotile Mesothelioma Risk
➡️ http://MesotheliomaUSA.net




CHRYSOTILE MESOTHELIOMA RISK.

The risk of mesothelioma from exposure to chrysotile asbestos.


Purpose of review.

This review assesses the risk of developing diffuse malignant mesothelioma of the pleura from exposures to chrysotile fibers and contrasts it with the known risk of amphibole asbestos.

Recent findings.

Although a rare cancer, the mortality rates of pleural mesothelioma continue to be significantly elevated because of past occupational exposures to airborne asbestos fibers. New analyses of occupational epidemiologic studies for highly exposed workers show a substantially lower potency and suggest an empiric threshold for chrysotile compared with amphibole asbestos. Important kinetic and pathological differences between chrysotile and amphiboles have been substantiated that support chrysotile's impotency in causing pleural mesothelioma.

Summary.

Excess risk of pleural mesothelioma from past exposures to asbestos, as evidenced by a trend of high incidence rates during the last half century, appears to be the result of nonchrysotile asbestiform fibers. Although scientific efforts and legal arguments continue, the risk of pleural mesothelioma in human populations is probably negligible for exposures to airborne chrysotile asbestos that is not known to be contaminated by amphibole. This distinction for asbestos fiber types is pivotal for understanding hazards and characterizing risks of continued use of natural chrysotile asbestos today and also new nanofibers.

Chrysotile Mesothelioma Risk - Is Mesothelioma Always Caused by Asbestos Exposure?
https://www.youtube.com/watch?v=X6MWHzehmas
https://www.youtube.com/channe....l/UCOVJwa1zpdmoeq2db

#ismesotheliomaalwayscausedbyasbestosexposure #mesotheliomariskfromchrysotile #chrysotilemesotheliomarisk #doeschrysotilecausemesothelioma

🔗 https://journals.lww.com/co-pu....lmonarymedicine/Abst

Anti Cancer Diet Interview - In this interview we ask - "You have a chapter on the role of nutrition and diet when dealing with cancer. Can you tell us a little more?"
https://survivingmesothelioma.....com/mesothelioma-new

A good diet for cancer patients is a very important thing to increasing the chance of survival. People often ask what foods to eat when you have cancer, and Paul Kraus' book on Cancer survival goes into just that. You can get a copy of his survival guide to mesothelioma and other cancers here: https://survivingmesothelioma.....com/mesothelioma-new

Bernie Siegel, M.D., a Yale trained Assistant Clinical Professor of General and Pediatric Surgery says, "Paul Kraus' book has all the information a cancer patient needs to have in order to learn what survival behavior is about..."

This is the only book of its kind written by an actual mesothelioma survivor and the only website where it is available for free. We only have a limited number of complimentary copies so this offer is only available to newly diagnosed mesothelioma patients. Get your free copy today before we run out.

https://survivingmesothelioma.....com/mesothelioma-new

Get that checked out

Patreon: https://www.patreon.com/SyntheticSoundsmith
TikTok: https://www.tiktok.com/@thesyntheticsoundsmith
Instagram: https://www.instagram.com/syntheticsoundsmith/

New York mesothelioma lawyer Joe Williams describes how long asbestos exposure takes to develop into the cancer known as mesothelioma. Contact Joe Williams at (855) 805-6376 for a consultation

You can also visit us on the web at : http://www.williamstriallawyers.com/

Are there different types of mesothelioma?
➡️ http://MesotheliomaUSA.net




0:23 Types of Mesothelioma By Location & Cell Type
1:00 Primary types of mesothelioma by location and cell type
1:22 Rare types of mesothelioma by location and cell type
1:54 Pleural Mesothelioma
2:22 Characteristics of Pleural Mesothelioma
2:42 Peritoneal Mesothelioma
3:10 Characteristics of Peritoneal Mesothelioma
3:32 Pericardial Mesothelioma
3:48 Characteristics of Pericardial Mesothelioma
4:08 Testicular Mesothelioma
4:30 Characteristics of Testicular Mesothelioma
4:48 Three Types of Mesothelioma Cells
5:29 Epithelial Cell Mesothelioma
6:01 Sarcomatoid Cell Mesothelioma
6:36 Biphasic

Are there different types of mesothelioma?
https://www.youtube.com/watch?v=axqdClPuUZA
https://www.youtube.com/channe....l/UCOVJwa1zpdmoeq2db

#aretheredifferentkindsofmalignantmesothelioma #aretheredifferenttypesofmesothelioma #howmanytypesofmesotheliomaarethere #ismesotheliomacommon #ismesotheliomarare #whatarethetwokindsofmesothelioma #whatarethetwotypesofmesothelioma

🔗 https://www.asbestos.com/mesothelioma/types/

Mesothelioma After Pneumonectomy
➡️ http://MesotheliomaUSA.net




Objective.

We review our 24-year experience with extrapleural pneumonectomy (EPP) in the treatment of epithelioid malignant pleural mesothelioma (MPM).

Background.

Recent publications, particularly the MARS (Mesothelioma and Radical Surgery) feasibility study by Treasure et al, have questioned the safety and efficacy of EPP for MPM.

Methods.

An institutional review board–approved, prospective, single-center database was retrospectively reviewed. Descriptive statistics and Kaplan-Meier analysis of overall survival are reported.

Results.

From 1988 to 2011, a total of 529 patients with epithelioid MPM underwent complete resection by EPP as part of a multimodality strategy. Among these, 131 (25%) were women, and the median age was 59 (range, 17–79) years. Median postoperative hospital stay was 10 (range, 1–101) days. Twenty-six patients (5%) experienced 30-day or in-hospital mortality. Median overall survival was 18 months, with 1-, 3-, 5-, and 10-year survival rates of 67%, 28%, 14%, and 4%, respectively. Outcome by pathologic lymph node status (N, median overall survival) was N0: 224, 26 months; N1: 118, 17 months; N2: 181, 13 months; N3: 5, 7 months; Nx: 1, not evaluable.

Conclusions.

EPP has evolved as an effective method for macroscopic complete resection. This study confirms that lymph node status is significantly correlated with overall survival in patients with epithelioid MPM undergoing EPP and suggests that those with simultaneous involvement of N1 and N2 stations are at increased risk. This observation underscores the need for thorough staging of both N1 and N2 stations and has implications for revision of MPM staging criteria.

Keywords: epithelioid mesothelioma, extrapleural pneumonectomy, macroscopic complete resection, malignant pleural mesothelioma, multimodality therapy

Mesothelioma After Pneumonectomy - Left Extrapleural Pneumonectomy For Pleural Mesothelioma (Lepm)
https://www.youtube.com/watch?v=-HIcsr9QpkY
https://www.youtube.com/channe....l/UCOVJwa1zpdmoeq2db

#howdoespleuralmesotheliomaprogress #howlongdoyouliveafterbeingdiagnosedwithmesothelioma #howlongdoyoulivewithmesothelioma #mesotheliomaafterpneumonectomy #whatarethechancesofsurvivingmesothelioma #whatdoesmesotheliomadotothelungs

🔗 https://www.ncbi.nlm.nih.gov/p....mc/articles/PMC44811